Last updated on March 2020

Plasma Biomarkers C-RAC ICORG 12-27 V1


Brief description of study

This is an exploratory, translational, non-interventional and multi-centre clinical study.

Detailed Study Description

Cohort A will consist of 100 CRAC patients with stage II/III resectable disease due for adjuvant chemotherapy.

Cohort B will consist of 30 patients with stage II resectable disease for observation only.

Both cohorts will have a follow up period of up to 2 years, post chemotherapy for cohort A and post resection for cohort B.

Clinical Study Identifier: NCT02050737

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.